Evaluation of post-COVID symptoms of the SARS-CoV-2 Delta and Omicron variants in children: a prospective study
- PMID: 37526704
- DOI: 10.1007/s00431-023-05134-6
Evaluation of post-COVID symptoms of the SARS-CoV-2 Delta and Omicron variants in children: a prospective study
Abstract
The post-COVID-19 syndrome is a new syndrome defined in patients with a history of probable or confirmed SARS-CoV-2 infection, usually within three months of the onset of COVID-19, with symptoms and effects lasting at least 2 months. This study is aimed at comprehensively comparing symptoms of the post-COVID-19 syndrome in children with Delta and Omicron variants. This prospective study included children with COVID-19 followed in hospitalized or outpatient clinics in a tertiary hospital. We used a special questionnaire to ask about the presence of persistent symptoms more than 12 weeks after the initial diagnosis. Patients with positive SARS-CoV-2 PCR were selected randomly and grouped according to the dominant variants in our country at that time as follows: Omicron group (after December 16, 2021); Delta (B.1.617.2) group (August 15, 2021, and December 15, 2021). This study included 200 children, 71 of whom were in the Delta group and 129 of whom were in the Omicron group. Weakness (8.5% vs. 1.6%; p = 0.017), the impact of physical efforts (5.6% vs. 3.9%; p = 0.020), fatigue (22.5% vs. 8.5%; p = 0.009), anxiety disorder (12.7% vs. 0.8%; p = 0.001), and gastrointestinal changes (12.7% vs. 4.7%, p = 0.050) were statistically significantly higher in patients with the Delta variant compared to patients with the Omicron variant. There were no differences between the groups regarding anorexia, anosmia/ageusia, arthralgia, influenza-like symptoms, sleeping disorders, decreased physical activity daily, headache, need for analgesia, concentration and memory disorder, and weight loss (p > 0.05). Conclusion: This study showed that weakness, the impact of physical efforts, fatigue, anxiety disorder, and gastrointestinal changes were more frequent in the Delta group compared to the Omicron group. The incidence of post-COVID-19 syndrome is high in children as well as adults and affects several systems; therefore, it should be kept in mind that children should be followed for post-COVID-19 syndrome. What is Known: • Despite the milder severity of acute COVID-19 in children, post-COVID-19 symptoms may occur. The post-COVID-19 condition is complex and novel, especially in the pediatric population. What is New: • Post-COVID-19 symptoms in children differ depending on the viral variant. Post-COVID-19 syndrome has a great impact on the social life of children which may have serious and long-term effects.
Keywords: Children; Delta; Omicron; Post-COVID.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.Clin Infect Dis. 2023 Jun 8;76(11):1930-1941. doi: 10.1093/cid/ciad045. Clin Infect Dis. 2023. PMID: 36705268 Free PMC article.
-
Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).BMC Med. 2024 Feb 1;22(1):48. doi: 10.1186/s12916-023-03221-x. BMC Med. 2024. PMID: 38302974 Free PMC article.
-
Post-COVID Syndrome: The Stranger Ghost of Culprit COVID-19.J Assoc Physicians India. 2023 Feb;71(2):11-12. doi: 10.5005/japi-11001-0193. J Assoc Physicians India. 2023. PMID: 37354471
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 20;5:CD013665. doi: 10.1002/14651858.CD013665.pub3. PMID: 33620086 Free PMC article. Updated.
-
Trends in Long COVID Symptoms in Japanese Teenage Patients.Medicina (Kaunas). 2023 Jan 29;59(2):261. doi: 10.3390/medicina59020261. Medicina (Kaunas). 2023. PMID: 36837463 Free PMC article. Review.
Cited by
-
Differences in the Clinical Manifestations and Host Immune Responses to SARS-CoV-2 Variants in Children Compared to Adults.J Clin Med. 2023 Dec 26;13(1):128. doi: 10.3390/jcm13010128. J Clin Med. 2023. PMID: 38202135 Free PMC article. Review.
-
Impact of Long SARS-CoV-2 Omicron Infection on the Health Care Burden: Comparative Case-Control Study Between Omicron and Pre-Omicron Waves.JMIR Public Health Surveill. 2024 Sep 3;10:e53580. doi: 10.2196/53580. JMIR Public Health Surveill. 2024. PMID: 39226091 Free PMC article.
References
-
- World Health Organization (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV Post_COVID-19_condition-Clinical_case_definition- 2021.1. Accessed 30 November 2022
-
- Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A et al (2020) Long-term clinical outcomes in survivors of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med 52. https://doi.org/10.2340/16501977-2694
-
- Peghin M, Los-Arcos I, Hirsch HH, Codina G, Monforte V, Bravo C et al (2019) Community-acquired respiratory viruses are a risk factor for chronic lung allograft dysfunction. Clin Infect Dis 69:1192–7. https://doi.org/10.1093/cid/ciy1047 - DOI - PubMed
-
- Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC et al (2020) Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 6:00542–02020. https://doi.org/10.1183/23120541.00542-2020 - DOI - PubMed - PMC
-
- Jacobs LG, Paleoudis EG, Di Bari DL, Nyirenda T, Friedman T, Gupta A et al (2020) Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One 15:1–14. https://doi.org/10.1371/journal.pone.0243882 - DOI
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous